Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALIGLUCERASE ALFA vs TALIMOGENE LAHERPAREPVEC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TALIGLUCERASE ALFA vs TALIMOGENE LAHERPAREPVEC: Safety Overview

Metric TALIGLUCERASE ALFA TALIMOGENE LAHERPAREPVEC
Total FAERS Reports 453 1,475
Deaths Reported 48 164
Death Rate 10.6% 11.1%
Hospitalizations 92 286
Average Patient Age 52.2 yrs 66.7 yrs
% Female Patients 38.1% 48.3%
Manufacturer Pfizer Laboratories Div Pfizer Inc Amgen Inc
Route INTRAVENOUS INTRALESIONAL
Marketing Status Prescription N/A